Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

Jul 20, 2017

|

NEW YORK (GenomeWeb) – A research team led by the University of California, Berkeley's Jennifer Doudna has discovered that the Cas1-Cas2 complex interacts with DNA based on its own structural features, rather than through direct recognition of the DNA sequence.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

COVAX's First Shipment

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.

Support for Another

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.

New Prototype Test

Researchers in France are developing a new, fast test for SARS-CoV-2 that initial testing indicates may be highly accurate, the Guardian says.

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

In Cell this week: analysis of fitness patterns among SARS-CoV-2 isolates, single-cell transcriptome analysis of immune features in COVID-19, and more.

Featured White Papers

Compatibility of Liquid Biopsy Assays on Multiple Sequencing Platforms

CAS-CLOVER The clean alternative to CRISPR/Cas9 for gene editing in the drug discovery and development industry

Mar

09

Featured Webinar

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

The growth of next-generation sequencing (NGS) testing presents both opportunities and challenges for clinical, informatics, and laboratory teams.

Mar

11

Featured Webinar

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

In this session, the third in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified gene fusions that may or may not serve as druggable targets.

Mar

24

Featured Webinar

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

This webinar, the first in a “Women in Single Cell” series sponsored by Mission Bio, will discuss the use of single-cell analysis to assess genome editing for use in pre-clinical disease modeling.

Menu

Cas1-Cas2 Integrase Structures Enable Bacteria to Adapt to New Viruses

To read the full story....

Breaking News

Crown Bioscience, Cambridge Quantum Computing Partner on Cancer Biomarker Discovery

Glaucoma GWAS Meta-Analysis Uncovers New Risk Loci, Shared Risk Across Ancestry Groups

Qiagen, Inovio Expand CDx Partnership, Starting With NGS Test for Cervical Dysplasia Therapy

NeoGenomics Q4 Revenue Grows 18 Percent, CEO to Retire

BioMérieux Reports 21 Percent Revenue Growth in Q4

WuXi Diagnostics Closes $150M Series B Financing Round

The Scan

COVAX's First Shipment

Support for Another

New Prototype Test

Cell Studies on SARS-CoV-2 Spike Variant, Host Transcriptomes, Glioma-Infiltrating T Cells

Featured White Papers

Implementation of Whole-Exome and Virtual Panel Testing for Rare Disease at a Children’s Hospital

Virtual Molecular Tumor Board Series: Gene Fusions as Druggable Targets

Single-Cell Analysis and Genome Editing in Preclinical Disease Modeling: Detailed Insights into Leukemia Lineage

What's Popular?

Cytosine Base Editors Allow Scientists to Study Function of Variants at Scale

ERS Genomics Licenses CRISPR Patents to Korean Biotech Firm G+FLAS Life Sciences

Sponsorships